High-Volume Scanners

WHITE PAPERS AND CASE STUDIES

• Tailoring Bioanalytical Testing In A New Era Of Drug Development

  Learn why pharmaceutical companies have to perform a comprehensive battery of tests to ensure product quality, safety, efficacy, purity, and stability through qualitative and quantitative characterization.

• Revolutionizing Particle Characterization With Image Analysis And ML

  The biopharmaceutical industry is increasingly employing micro-flow imaging for particle characterization, owing to the superior insights it can afford into product quality and process controls.

• Generation Of Stable CHO Cell Lines For Protein Production

  By following the five steps of a specialized protocol, exceptional yields and stable cell lines can be achieved in CHO cells using antibiotic selection.

• Spray Drying To Enable New Inhaled Drug Products

  The formulation and spray drying process can help manufacture a stable, highly respirable powder and deliver products that require a high drug load, a biologic, or rapid onset therapeutic.

• How Early-Stage Planning Strategies Are Optimizing Drug Development

  Early integration of a target product profile (TPP) into early-stage planning is pivotal for steering drug development toward both regulatory success and commercial impact.

• Developing A Data Strategy For Clinical Trials

  This white paper outlines a standardized method for developing a data strategy that can be tailored to a company's current needs and adapted as those needs evolve.

• Buffalo, NY, Starts Successful Verification Program

  Verifying service line materials can be a daunting undertaking, especially when the system is old and the staff is small. Read about how Buffalo Water addresses these challenges. 

• How To Get Products To Patients Faster With A Connected QMS

  BioBridge Global faced challenges with paper-heavy processes that risked errors and delays. Discover how digital solutions streamlined their operations and improved regulatory efficiency.

• Increasing Batch Size And Reducing Cycle Times For A Biologic

  JHS partnered with a global pharma company to optimize biologic production, increasing output by 50% and reducing batch release times by up to 30%.

• BioIVT Collaborates With IDBS To Deploy IDBS E-WorkBook And Reduce Study Cycle Times

  Learn about a collaboration that has enabled BioIVT to enhance efficiency and responsiveness to its biopharmaceutical clients.

• Streamlining And Standardizing CGT From Process To Product

  Cell and gene therapies are transforming treatment, but rapid progress strains supply chains, requiring scaled manufacturing and increased capacity.

• Standardizing Content Management Across The Life Sciences Industry

  Explore a quality reference model that aims to foster further standardization within the life sciences industry, and discover the advantages of leveraging the standardized best practices within.